Skip to main content

Treadwell Therapeutics

New York, United States

Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.

$91.0M raised
Nov 2021
Series B

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Treadwell Therapeutics

How much funding has Treadwell Therapeutics raised?
Treadwell Therapeutics has raised $91.0M in total funding. The most recent round was Series B. The last funding was announced in November 2021.
Who are Treadwell Therapeutics's investors?
Treadwell Therapeutics's investors include Sino Biopharmaceutical, Adrian Cheng, 3W Fund Management, TIO Bioventures, Prosperous Alliance Investments.
Where is Treadwell Therapeutics headquartered?
Treadwell Therapeutics is headquartered in New York, United States.
What does Treadwell Therapeutics do?
Treadwell Therapeutics is a clinical-stage oncology company that develops medicines to address unmet needs in patients with cancer.
What stage is Treadwell Therapeutics at?
Treadwell Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Treadwell Therapeutics — Funding & Investors." VCBacked, November 18, 2021, https://www.vcbacked.co/company/treadwell-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2021). Treadwell Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/treadwell-therapeutics
Wikipedia (cite web)
{{cite web |title=Treadwell Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/treadwell-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .